Cargando…
Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia
SIMPLE SUMMARY: The chromosomal alteration t(9;22) generating the BCR-ABL1 fusion protein represents the principal feature that distinguishes some types of leukemia. An increasing number of articles have focused the attention on the relevance of protein phosphatases and their potential role in the c...
Autores principales: | Boni, Christian, Sorio, Claudio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151247/ https://www.ncbi.nlm.nih.gov/pubmed/34065882 http://dx.doi.org/10.3390/cancers13102311 |
Ejemplares similares
-
Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients
por: Ismail, Mohamed A., et al.
Publicado: (2022) -
Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
por: Ismail, Mohamed A., et al.
Publicado: (2021) -
The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer
por: Boni, Christian, et al.
Publicado: (2022) -
A Comprehensive Review of Receptor-Type Tyrosine-Protein Phosphatase Gamma (PTPRG) Role in Health and Non-Neoplastic Disease
por: Boni, Christian, et al.
Publicado: (2022) -
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia
por: Tomasello, Luisa, et al.
Publicado: (2020)